Published in PLoS One on February 18, 2014
Clinical implications of interferon-γ genetic and epigenetic variants. Immunology (2014) 0.85
The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs. PLoS One (2015) 0.79
Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis. BMC Bioinformatics (2016) 0.77
Interleukin-17 family members and inflammation. Immunity (2004) 16.16
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98
Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol (2000) 6.57
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol (2006) 5.27
Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol (1999) 4.77
Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol (1988) 4.47
IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol (2007) 4.23
A standard curve based method for relative real time PCR data processing. BMC Bioinformatics (2005) 3.85
Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl (1968) 3.41
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol (2001) 3.06
Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood (2007) 2.92
Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79
Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77
Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol (1997) 2.74
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol (2002) 2.67
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology (1996) 2.65
Trafficking and release of mycobacterial lipids from infected macrophages. Traffic (2000) 2.65
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol (1999) 2.44
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol (2001) 2.32
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol (2004) 2.27
Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol (2002) 2.17
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16
Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol (2007) 2.15
Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe (2008) 2.13
Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun (2001) 1.97
Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol (2011) 1.90
IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev (2010) 1.86
Immunology of tuberculosis. Indian J Med Res (2004) 1.80
Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest (1999) 1.74
Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun (2004) 1.73
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun (2006) 1.62
Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis (2002) 1.61
Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol (2008) 1.58
Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol (2003) 1.57
Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med (2009) 1.54
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol (1999) 1.53
Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51
Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. Eur J Cell Biol (2001) 1.50
Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem (2005) 1.34
Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun (2004) 1.31
Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis (2003) 1.21
Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol (2010) 1.21
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res (2006) 1.20
Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol (2001) 1.20
Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) (2009) 1.20
Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med (1998) 1.17
Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection. Microbes Infect (2003) 1.17
Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis. J Bras Pneumol (2008) 1.08
Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol (1990) 1.07
Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis (Edinb) (2005) 1.02
Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol (2006) 1.01
TB, or not TB: that is the question -- does TLR signaling hold the answer? J Clin Invest (2004) 1.01
Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect Immun (1997) 1.01
Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm (2005) 0.99
Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J Clin Invest (1996) 0.94
TLR2 and TLR4 expression on the immune cells of tuberculous pleural fluid. Immunol Lett (2007) 0.92
The molecular mechanisms of Foxp3 gene regulation. Semin Immunol (2011) 0.91
Roles of NF-kappaB activation and peroxisome proliferator-activated receptor gamma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells. Antimicrob Agents Chemother (2008) 0.82
Peripheral DNA damage in active pulmonary tuberculosis. Environ Toxicol (2011) 0.76
Mechanisms of immunity in tuberculosis. Pathobiol Annu (1979) 0.76